Literature DB >> 3000573

Estrogen receptors in hepatocellular carcinoma.

N Nagasue, A Ito, H Yukaya, Y Ogawa.   

Abstract

Estrogen receptors (ER) were assayed on hepatocellular carcinoma (HCC) and surrounding liver tissue in 30 adult patients. All specimens were obtained at the time of surgery. Cirrhosis of the liver was associated with 28 patients and chronic hepatitis in 2 patients. ERs were detected in 12 of 30 HCCs. The value ranged from 1.4 to 9.2 fmol/mg cytosol protein with the dissociation constant (Kd) value less than 1 nanomol. On the other hand, 13 of 28 cirrhotic livers had measurable amounts of the receptors that ranged from 1.5 to 4.1 fmol/mg cytosol protein. Two livers with chronic hepatitis did not have detectable amounts of ERs. The receptors were not detected in both the tumor and liver in ten patients. The ER titers in HCC did not have any correlation with serum levels of alpha-fetoprotein or carcinoembryonic antigen, hepatitis B virus profiles, and histologic types of the tumor. In the light of the current results, it would be of great interest whether hormone therapy can be used or not as a treatment of naturally occurring HCC in humans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3000573     DOI: 10.1002/1097-0142(19860101)57:1<87::aid-cncr2820570118>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  CAF versus CAF plus Medroxyprogesterone Acetate for Treatment of Liver Metastases of Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

2.  Estrogen receptors in hepatocellular carcinoma: is endocrine therapy for hepatocellular carcinoma likely to be effective?

Authors:  K Kohigashi; Y Fukuda; H Imura
Journal:  Gastroenterol Jpn       Date:  1987-06

3.  Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection.

Authors:  N Nagasue; Y C Chang; T Hayashi; G Galizia; H Kohno; T Nakamura; H Yukaya
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

4.  Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas.

Authors:  N Nagasue; H Kohno; Y C Chang; A Yamanoi; T Nakamura; H Yukaya; T Hayashi
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

Review 5.  Is human hepatocellular carcinoma a hormone-responsive tumor?

Authors:  Massimo Di Maio; Bruno Daniele; Sandro Pignata; Ciro Gallo; Ermelinda De Maio; Alessandro Morabito; Maria-Carmela Piccirillo; Francesco Perrone
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

6.  Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver.

Authors:  P K Eagon; A Francavilla; A DiLeo; M S Elm; L Gennari; V Mazzaferro; G Colella; D H Van Thiel; T E Strazl
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

7.  Detection of androgen receptors in human esophageal cancer.

Authors:  Y Yamashita; T Hirai; H Mukaida; K Kawano; T Toge; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1989-03

8.  Oral contraceptives and primary liver cancer among young women.

Authors:  A W Hsing; R N Hoover; J K McLaughlin; H T Co-Chien; S Wacholder; W J Blot; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

Review 9.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

Review 10.  Evolution of systemic therapy of advanced hepatocellular carcinoma.

Authors:  Thomas Yau; Pierre Chan; Richard Epstein; Ronnie-T Poon
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.